RE: Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence.
Ellsworth
Pamela
P
D001559:Benzhydryl Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D003408:Cresols / Q000008:administration & dosage / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004304:Dosage Forms; D006801:Humans; D008333:Mandelic Acids; D010665:Phenylpropanolamine; D012107:Research Design; D012189:Retrospective Studies; D013644:Tartrates / Q000008:administration & dosage / Q000627:therapeutic use*; D000068737:Tolterodine Tartrate; D014549:Urinary Incontinence / Q000188:drug therapy*
D001559:Benzhydryl Compounds; D018680:Cholinergic Antagonists; D003408:Cresols; D003692:Delayed-Action Preparations; D004304:Dosage Forms; D008333:Mandelic Acids; D013644:Tartrates; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate; C005419:oxybutynin